Comparison of solutions for sublingual immunotherapy

International Archives of Allergy and Immunology

Volumn 142, Issue 1, 2006, Pages 89-90

  Bachert, Claus ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN;

BIOLOGICAL ACTIVITY; CLINICAL STUDY; IMMUNOTHERAPY; LETTER; PHYSICIAN; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; DESENSITIZATION, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; SOLUTIONS; THERAPEUTIC EQUIVALENCY; TREATMENT OUTCOME;

EID: 33845937985     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096033     Document Type: Letter

References (4)

1. Mosges R, Pasch N, Schlierenkamper U, Lehmacher W: Comparison of the biological activity of the most common sublingual allergen solutions made by two European manufacturers. Int Arch Allergy Immunol 2006;139:325-329.
2. Bachert C: Heisst hohe Dosis unbedingt auch hohe Wirksamkeit? Allergo J 2006;15:28.
3. Malling HJ: Is sublingual immunotherapy clinically effective? Curr Opin Allergy Clin Immunol 2002;2:523-531.
4. Wilson DR, Torres LI, Durham SR: Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev 2003; CD002893.